Who founded Collimate Health?

Collimate Health was founded by Stefan Bartzsch, Johanna Winter, Hans Maria Heÿn in 2026.

Who are Collimate Health's investors?

Collimate Health's investors include Positron Ventures, xista science ventures, Caesar Ventures, HTGF.

Collimate Health

Founded 2026 · 11 employees on LinkedIn · 5 known investors

Find your way into Collimate Health

Paths you didn't know you had: your email and LinkedIn already hold routes to the Collimate Health team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

CollimateHealth develops a clinically scalable microbeam radiation technology for cancer treatment, delivering arrays of narrow, micrometer-scale radiation beams at higher doses than conventional broad-beam radiation oncology. The technology aims to trigger immune responses against cancer cells and improve delivery of chemotherapy and immunotherapy into tumor tissue.

Biotech Healthtech Medical Devices

Founders & leadership

Collimate Health was founded in 2026 by Stefan Bartzsch, Johanna Winter, and Hans Maria Heÿn.

Stefan BartzschCo-founder & Chief Scientific OfficerCo-founder & Chief Scientific Officer at CollimateHealth

Johanna WinterCo-founder & Chief Technology OfficerCo-founder & Chief Technology Officer at CollimateHealth

Hans Maria HeÿnCo-founder & Chief Executive OfficerCo-founder and CEO of CollimateHealth, which develops a clinically scalable microbeam radiation technology for cancer treatment. He has over 15 years of experience in in-vitro diagnostics, medical device, and health-tech development, including MDR and IVDR regulatory requirements and leading international product development teams.

Investors · 5

Positron Ventureslisted by Positron VenturesAmsterdam

How we know: pulse2.com · Not right? Tell us

xista science ventureslisted by xista science venturesKlosterneuburg · $162K – $4.3M

How we know: xista science ventures's portfolio page · pulse2.com · Not right? Tell us

Caesar VenturesreportedBerlin

How we know: pulse2.com · Not right? Tell us

HTGFreportedBonn · $880K – $33M

How we know: pulse2.com · funding news · Not right? Tell us

Also in the syndicate · 1

VP Venture Partners

Funding

SEC filings, press & company announcements

Undisclosed amountSeedJun 2026 · 2 sources
caesar, High-Tech Gründerfonds (HTGF), Positron, VP Venture Partners, xista science ventures
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Press release: CollimateHealth Targets Immune Responses Through Microbeam Therapy - Medical Valleymedical-valley-emn.de · Jun 2026

HTGF and VP Venture Partners back CollimateHealth's €6M bet that hair-thin radiation beams can out-compete chemotherapy — TFNtechfundingnews.com · Jun 2026

CollimateHealth Raises €6M in Seed Fundingfinsmes.com · Jun 2026

Frequently asked questions

What does Collimate Health do?: CollimateHealth develops a clinically scalable microbeam radiation technology for cancer treatment, delivering arrays of narrow, micrometer-scale radiation beams at higher doses than conventional broad-beam radiation oncology. The technology aims to trigger immune responses against cancer cells and improve delivery of chemotherapy and immunotherapy into tumor tissue.
Who founded Collimate Health?: Collimate Health was founded by Stefan Bartzsch, Johanna Winter, Hans Maria Heÿn in 2026.
Who are Collimate Health's investors?: Collimate Health's investors include Positron Ventures, xista science ventures, Caesar Ventures, HTGF.